...
首页> 外文期刊>American Journal of Veterinary Research >Evaluation of the function of polymorphonuclear neutrophilic leukocytes in healthy dogs given a high dose of methylprednisolone sodium succinate.
【24h】

Evaluation of the function of polymorphonuclear neutrophilic leukocytes in healthy dogs given a high dose of methylprednisolone sodium succinate.

机译:高剂量甲基强的松龙琥珀酸钠对健康犬中多形核嗜中性白细胞功能的评估。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To evaluate effects of a high dose of methylprednisolone sodium succinate (MPSS) on function of polymorphonuclear neutrophilic leukocytes (PMNs) in dogs. ANIMALS: 7 healthy male Beagles (body weight, 10.5 to 15 kg; age, 2 to 4 years). PROCEDURES: All dogs were treated by IV administration of a high dose of MPSS (30 mg/kg). Additional doses of MPSS (15 mg/kg) were administered IV at 2 and 6 hours and then at 6-hour intervals until 48 hours after the initial dose. Blood samples were collected before and 1, 2, 4, 7, and 14 days after completion of the MPSS administrations and used for evaluation of PMN functions. Isolated PMNs were used for assessment of functions, such as adhesion, migration, phagocytosis, and oxidative burst. RESULTS: On days 1, 2, and 4 after completion of MPSS administration, there was a decrease in PMN expression of adhesion markers such as CD11b and CD18. There was a decrease in the phagocytotic ability of PMNs on days 1, 2, and 7 after completion of MPSS administration, with a reduction in the oxidative burst of PMNs detected on day 7. No significant changes were identified for migration. All functional changes returned to their pretreatment values by 14 days after completion of MPSS treatment. CONCLUSIONS AND CLINICAL RELEVANCE: Treatment with a high dose of MPSS suppressed PMN functions in dogs. Analysis of these results suggested that treatment with a high dose of MPSS can suppress some of the major functions of PMNs for at least 7 days.
机译:目的:评估大剂量甲基泼尼松龙琥珀酸钠(MPSS)对狗多形核嗜中性白细胞(PMNs)功能的影响。动物:7只健康的雄性比格犬(体重10.5至15公斤;年龄2至4岁)。程序:所有狗均通过静脉内给予高剂量的MPSS(30 mg / kg)进行治疗。在第2和第6个小时静脉注射另外的MPSS剂量(15 mg / kg),然后每隔6小时注射一次,直到初始剂量后48小时为止。在完成MPSS给药之前和之后,1、2、4、7和14天收集血液样本,并将其用于评估PMN功能。分离的PMN用于评估功能,例如粘附,迁移,吞噬作用和氧化爆发。结果:在完成MPSS给药后的第1、2和4天,粘附标记(如CD11b和CD18)的PMN表达降低。在完成MPSS给药后第1、2和7天,PMN的吞噬能力降低,而在第7天检测到的PMN的氧化爆发减少。未发现迁移的显着变化。在MPSS治疗完成后的14天,所有功能改变都恢复到其预处理值。结论和临床意义:用高剂量的MPSS治疗可抑制狗的PMN功能。对这些结果的分析表明,高剂量的MPSS治疗可以抑制PMN的某些主要功能至少7天。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号